In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...

Americans' median household income rose to $87,460, or 2.6%, in 2025, the first year of President Donald Trump's second term, according to Census Bureau data released Tuesday. This is the highest ...

(NEXSTAR) – Median household income in the U.S. has reached new heights, the Census Bureau revealed in a data drop on Tuesday. The median household made $87,460 in 2025, the Census reported. Adjusted ...

Static-X have sued Matt Zicari, also known as "Matt Zane" and "Lord Zane," for sharing alleged unauthorized footage and he's issued a response. Loudwire obtained copies of the lawsuit and a subsequent ...

Galien Grosjean was a caretaker of tiny glass beads. He bathed them, gently cradled them with tweezers, placed them delicately in his experimental apparatus. He avoided unneeded jostling at all costs: ...

Median Strategies, the company that released polls showing Los Angeles Mayor Karen Bass (D) and former Wisconsin gubernatorial candidate Francesca Hong ahead with wide margins in their respective ...

LOS ANGELES (CNS) -- A widely shared poll that showed Mayor Karen Bass leading City Councilwoman Nithya Raman by nearly 12 percentage points ahead of the Nov. 3 mayoral runoff was fake, according to a ...

A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized phase 3 RASolute 302 trial comparing daraxonrasib to ...

T-DXd demonstrated a real-world overall response rate of 56.3%, median rwPFS of 7.4 months, and 12-month OS of 62% in patients with HER2-low metastatic breast cancer treated across US community ...

Atebimetinib plus modified gemcitabine/nab-paclitaxel demonstrated an ORR of 36% and median OS of 17.3 months in first-line metastatic pancreatic cancer. Findings ...

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor–2 Rearrangement: Results From the Phase III FIGHT-302 Trial In this randomized, double-blind, ...

Venetoclax re-exposure — usually in combination with an anti-CD20 antibody or a Bruton tyrosine kinase (BTK) inhibitor — was associated with high overall response rates and promising progression-free ...